Droxicam
From Wikipedia, the free encyclopedia
|
Droxicam
|
|
| Systematic (IUPAC) name | |
| 2H,5H-1,3-Oxazino(5,6-c)(1,2)benzothiazine-2,4(3H)-dione, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide | |
| Identifiers | |
| CAS number | ? |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C16H11N3O5S |
| Mol. mass | 357.34064 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Droxicam is a non-steroidal anti-inflammatory drug.
|
|||||||||||||||||||||||||||||||||||

